TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2025

A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD.

Jennifer M Erichsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.